Skip to main content
. 2023 May 16;12(5):918. doi: 10.3390/antibiotics12050918
ADR adverse reaction
AMF amphotericin
CAP caspofungin
CEF/AVI ceftazidime/avibactam
CI confidence interval
COL colistin
DI drug ineffectiveness
DR drug resistance
EEA European Economic Area
EMA European Medicines Agency
EV EudraVigilance
FLU fluconazole
ICSR Individual Case Safety Report
ICU intensive care unit
ISA isavuconazole
LIN linezolid
LPS lipopolysaccharide
MER meropenem
MOX moxifloxacin
PBP penicillin-binding proteins
PIP/TAZ piperacillin/tazobactam
PTs preferred terms
ROR reporting odds ratio
TIG tigecycline
VAN vancomycin
VOR voriconazole